Drug Approval | March 29, 2022
Ozempic 2.0 mg approved in the US for the treatment of type 2 diabetes
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Ozempic is now approved in the US at 0.5 mg,1.0 mg and 2.0 mg doses for the treatment of type 2 diabetes in adults
Dupixent peak sales ambition raised to more than €13 billion
As a partner with IRIA, the company had a significant booth presence on-ground during the conference.
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
John Shaw, who is a Glasgow University graduate, along with his wife Kiran Mazumdar-Shaw had gifted US $ 7.5 million to the university in July 2019
The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
Launched in the year 2018, MedEngage Scholarship Program is aimed at nurturing and nourishing medical talent in India
This targeted capacity-building and advocacy project in 15 districts and 5 states of India has facilitated the certification of disability for 11,152 people, provided disability pensions to 8,144 people and supported the issuing of voter IDs to 8,450 people with disabilities
Subscribe To Our Newsletter & Stay Updated
